Merck stock hits 52-week high as vaccine policy shift and JPM conference loom
New York, Jan 6, 2026, 14:16 EST — Regular session Merck & Co shares rose about 1.1% to $108.60 in afternoon trading on Tuesday and earlier hit a 52-week high of $110.16. The broader S&P 500 and the Health Care Select Sector SPDR Fund were also higher. The stock has drawn fresh attention after Merck said CEO Robert M. Davis…